首页 > 抗体蛋白 > 抗体
Purified anti-mouse/human CD45R/B220 Antibody
产品名称:
Purified anti-mouse/human CD45R/B220 Antibody
产品类别:
抗体
产品编号:
103201
产品应用:
103201
[价格]
规格 价格 库存
50µg ¥ 420 1

产品详情

Product Details

Verified Reactivity
Mouse, Human
Reported Reactivity
Cat
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Abelson murine leukemia virus-induced pre-B tumor cells
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C.
Application

FC - Quality tested
CyTOF?, IHC-F - Verified
IHC-P, IP, Activ - Reported in the literature, not verified in house

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 ?g per 106 cells in 100 ?l volume. For immunohistochemistry on frozen tissue sections, a concentration range of 5.0 - 10 ?g/ml is suggested. It is recommended that the reagent be titrated for optimal performance for each application.

Application Notes

Clone RA3-6B2 has been described to react with an epitope on the extracellular domain of the transmembrane CD45 glycoprotein which is dependent upon the expression of exon A and specific carbohydrate residues. Additional reported applications (for the relevant formats) include: immunoprecipitation1, in vitro and in vivo modulation of B cell responses2-4, immunohistochemistry of acetone-fixed frozen sections and formalin-fixed paraffin-embedded sections5,6, and spatial biology (IBEX)14,15.

Application References

(PubMed link indicates BioLegend citation)
  1. Coffman RL. 1982. Immunol. Rev. 69:5. (IP)
  2. George A, et al. 1994. J. Immunol. 152:1014. (Activ)
  3. Asensi V, et al. 1989. Immunology 68:204. (Activ)
  4. Domiati-Saad R, et al. 1993. J. Immunol. 151:5936. (Activ)
  5. Hata H, et al. 2004. J. Clin. Invest. 114:582. (IHC)
  6. Monteith CE, et al. 1996. Can. J. Vet. Res. 60:193. (IHC)
  7. Shih FF, et al. 2006. J. Immunol. 176:3438. (FC)
  8. Chang C L-T, et al. 2007. J. Immunol. 178:6984.
  9. Fazilleau N, et al. 2007. Nature Immunol. 8:753.
  10. Lang GL, et al. 2008. Blood 111:2158. PubMed
  11. Charles N, et al. 2010. Nat. Med. 16:701. (FC) PubMed
  12. del Rio ML, et al. 2011. Transpl. Int. 24:501. (FC) PubMed
  13. Murakami R, et al. 2013. PLoS One. 8:73270. PubMed
  14. Radtke?AJ,?et al.?2020.?Proc Natl Acad Sci U S A.?117:33455-65. (SB)?PubMed
  15. Radtke?AJ,?et al.?2022.?Nat Protoc.?17:378-401. (SB)?PubMed
Product Citations
  1. Dallari S, et al. 2017. Nat Commun. 8:14830. PubMed
  2. Wolf Y, et al. 2017. J Exp Med. 214:905. PubMed
  3. Luo W, et al. 2019. Nat Immunol. 20:736. PubMed
  4. Kobayashi A, et al. 2021. Front Immunol. 12:650856. PubMed
  5. Gern BH, et al. 2021. Cell Host Microbe. 29(4):594-606.e6. PubMed
  6. Mazor R, et al. 2018. Proc Natl Acad Sci U S A. 115:E733. PubMed
  7. Chartrand K, et al. 2018. Front Immunol. 1.642361111. PubMed
  8. Baja?a S, et al. 2021. Front Immunol. 11:577718. PubMed
  9. Khan KA, et al. 2020. NPJ Breast Cancer. 6:29. PubMed
  10. Goel S, et al. 2017. Nature. 548:471. PubMed
  11. Fonseca JA, et al. 2018. Vaccine. 36:2799. PubMed
  12. Arnold IC, et al. 2018. J Exp Med. 215:2055. PubMed
  13. Plumlee CR, et al. 2020. Cell Host Microbe. 29(1):68-82.e5. PubMed
  14. Chen L, et al. 2019. Nat Commun. 3.553472222. PubMed
  15. Periasamy S, et al. 2017. Nat Commun. 8:15564. PubMed
  16. Mayer JU, et al. 2020. Front Immunol. 11:592325. PubMed
  17. Son YM, et al. 2020. Eur J Immunol. 50:1067. PubMed
  18. Tian K, et al. 2021. J Immunol Res. 2021:6297332. PubMed
  19. Nguyen N, et al. 2022. iScience. 25:103679. PubMed
  20. Schafflick D, et al. 2020. Nat Commun. 247:11. PubMed
  21. Grohmann M et al. 2018. Cell. 175(5):1289-1306 . PubMed
  22. Ng SR, et al. 2020. Proc Natl Acad Sci U S A. 117:513. PubMed
  23. Niss Arfelt K, et al. 2017. Blood. 129:866. PubMed
  24. Conlon TM, et al. 2020. Nature. 588:151. PubMed
  25. Stebegg M, et al. 2019. Nat Commun. 2.113194444. PubMed
  26. McLeod RL, et al. 2018. Oncotarget. 9:34459. PubMed
  27. De Schepper S et al. 2018. Cell. 175(2):400-415 . PubMed
  28. Lee JH, et al. 2022. iScience. 25:104166. PubMed
  29. Peng V, et al. 2020. J Biol Chem. 295:14866. PubMed
  30. Yang M, et al. 2020. Oncoimmunology. 9:1708064. PubMed
  31. Sugita J, et al. 2021. Nat Commun. 12:1910. PubMed
  32. Adamson SE, et al. 2018. Arterioscler Thromb Vasc Biol. 38:1020. PubMed
  33. Dubey LK, et al. 2019. Cell Rep. 27:2442. PubMed
  34. Sun H, et al. 2018. J Cell Biol. 217:1453. PubMed
  35. Chen S, et al. 2018. Immunohorizons. 0.345138889. PubMed
  36. Khan KA, et al. 2020. NPJ Breast Cancer. 6:29. PubMed
  37. Baluk P, et al. 2020. Am J Pathol. 190:2355. PubMed
  38. Suzuki Y, et al. 2021. FEBS Open Bio. 11:2619. PubMed
  39. Seelige R, et al. 2018. Sci Rep. 8:13670. PubMed
  40. Piliponsky AM, et al. 2019. Nat Immunol. 0.922916667. PubMed
  41. Zhao L, et al. 2018. Nat Med. 24:1536. PubMed
  42. Manni M, et al. 2018. Nat Immunol. 1.074305556. PubMed
  43. Stacey MA, et al. 2017. J Clin Invest. 127:1463. PubMed
  44. Quaranta V, et al. 2018. Cancer Res. 2018:5379085. PubMed
  45. Dungubat E, et al. 2020. Nutrients. 12:00. PubMed
  46. Ma W, et al. 2017. Sci Rep. . 10.1038/s41598-017-15661-6. PubMed
  47. Telford W, et al. 2017. Cytometry A. 91:314. PubMed
  48. Abboud G, et al. 2018. Front Immunol. 9:1973. PubMed
  49. Mainini F, et al. 2018. Nucleic Acid Ther. 28:225. PubMed
  50. Vukman KV, et al. 2020. J Extracell Vesicles. 10:e12023. PubMed
  51. Liu H, et al. 2020. J Immunol. 205:1207. PubMed
  52. Brown IK, et al. 2021. PLoS Pathog. 17:e1009602. PubMed
  53. Umemoto T, et al. 2017. EMBO J. 36:2390. PubMed
  54. Wan X, et al. 2018. Nature. 560:107. PubMed
  55. Cardoso F, et al. 2021. Nature. 597:410. PubMed
  56. Tran JQ, et al. 2020. Blood Adv. 4:5547. PubMed
  57. Lebert-Ghali C, et al. 2016. Blood. 127: 87-90. PubMed
  58. Davies CL, et al. 2019. Front Immunol. 10:1048. PubMed
  59. Shin J, et al. 2018. Diabetes. 67:1068. PubMed
  60. Schuler CF, et al. 2020. Allergy. 75:2279. PubMed
  61. Tao H, et al. 2021. Front Immunol. 12:623280. PubMed
  62. Murakami R, et al. 2013. PLoS One. 8:73270. PubMed
  63. King IL, et al. 2017. Mucosal Immunol. 10:1160. PubMed
  64. Nagatake T, et al. 2018. Int Immunol. 30:471. PubMed
  65. Gr?schel C, et al. 2017. Sci Rep.. 10.1038/s41598-017-16147-1. PubMed
  66. Chen HW, et al. 2021. Biomedicines. 9:. PubMed
  67. Baluk P, et al. 2018. Methods Mol Biol. 1846:161. PubMed
  68. Wang HC, et al. 2017. J Immunol. 198:3149. PubMed
  69. Parigi SM, et al. 2018. Sci Rep. 0.440277778. PubMed
  70. Yoon BH, et al. 2018. Mol Cells. 41:953. PubMed
  71. Lang G, et al. 2008. Blood. 111:2158. PubMed
  72. Ikezoe T, et al. 2021. Biomolecules. 11:. PubMed
  73. Kimishima Y, et al. 2021. Nat Commun. 12:6177. PubMed
  74. Rosenbaum M, et al. 2019. Nat Commun. 2.05. PubMed
  75. Wang W, et al. 2018. J Vasc Surg. 68:1538. PubMed
  76. Kawabe T, et al. 2017. Sci Immunol. 2:eaam9315. PubMed
  77. Kwok T, et al. 2022. Front Aging. 3:838943. PubMed
  78. Yin S et al. 2019. Cancer cell. 35(2):283-296 . PubMed
  79. Akiel M, et al. 2017. Cancer Res. 77:4014. PubMed
  80. Duncan CG, et al. 2018. G3 (Bethesda). 0.892361111. PubMed
  81. Simmons S et al. 2019. Elife. 8 pii: e41239. PubMed
  82. Chung WY, et al. 2018. ALTEX. 36:29. PubMed
  83. Link CWM, et al. 2020. Front Immunol. 11:596772. PubMed
  84. Lin Z, et al. 2021. Stem Cells. 39:240. PubMed
  85. Messal HA, et al. 2020. Nat Protoc. 16:239. PubMed
  86. Mohrin M, et al. 2021. Aging Cell. 20:e13313. PubMed
  87. Schnoegl D, et al. 2022. Front Immunol. 13:909270. PubMed
  88. Heib T, et al. 2021. Cell Reports. 35(6):109102. PubMed
  89. Feng X, et al. 2020. DNA Repair (Amst). 86:102754. PubMed
  90. Fujimura N, et al. 2016. J Vasc Surg. 64: 46-54. PubMed
  91. Englezou PC, et al. 2018. Mol Ther Nucleic Acids. 12:118. PubMed
  92. Cole C, et al. 2018. Nucleic Acids Res. 46:e62. PubMed
  93. Yamashita M, et al. 2019. Cell Stem Cell. 25:357. PubMed
  94. Diao J, et al. 2018. J Immunol. 201:1306. PubMed
  95. Chiu H, et al. 2017. Front Immunol. 0.852083333. PubMed
  96. Schneppenheim J, et al. 2017. J Immunol. 199:172. PubMed
  97. Ravell JC, et al. 2020. J Clin Invest. 130:507. PubMed
  98. Alrefai H, et al. 2016. Nat Commun. 7:11724. PubMed
  99. Ito Y, et al. 2018. J Exp Med. 215:2617. PubMed
  100. Nagashima K, et al. 2017. Biochem Biophys Res Commun. . 10.1016/j.bbrc.2017.09.004. PubMed
  101. K?stele V, et al. 2021. Mucosal Immunol. 14:717. PubMed
  102. Prabakaran T, et al. 2021. EBioMedicine. 66:103314. PubMed
RRID
AB_312986 (BioLegend Cat. No. 103201) AB_312987 (BioLegend Cat. No. 103202)

Antigen Details

Structure
Protein tyrosine phosphatase (PTP) family, 180-240 kD
Distribution

B cells, T cell subset, NK cell subset

Function
Phosphatase, T and B cell activation
Ligand/Receptor
Galectin-1, CD2, CD3, CD4
Cell Type
B cells, NK cells, T cells
Biology Area
Cell Biology, Immunology, Inhibitory Molecules, Neuroscience, Neuroscience Cell Markers
Molecular Family
CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Trowbridge IS, et al. 1993. Annu. Rev. Immunol. 12:85.
3. Kishihara K, et al. 1993. Cell 74:143.
4. Pulido R, et al. 1988. J. Immunol. 140:3851.

Gene ID
19264 View all products for this Gene ID 5788 View all products for this Gene ID
UniProt
View information about CD45R on UniProt.org

联系我们

TEL:021-34661275  点击拨打热线